Merck will split into two companies
-
Last Update: 2020-02-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On February 5, MSD released its Q4 and full year financial report in 2019, and announced a major news that it has decided to split MSD into two growth companies! MSD said it would spin off the franchises of women's health, patent brands and bio similar drugs and set up an independent listed company Kenneth C Frazier, chairman and CEO of MSD, announced the news, saying that by optimizing MSD's human health product portfolio, MSD could be closer to the company's goal of becoming a leading R & D-based biopharmaceutical company In today's financial report, we can see that in 2019, the annual sales of MSD reached 46.8 billion US dollars, of which the annual sales of keytruda, a heavy product in the field of cancer, reached 11.1 billion US dollars, an increase of 55%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.